A newly approved National Cancer Institute-funded clinical trial aims to improve survival for head and neck cancer patients whose disease returns after radiation therapy – a setback that affects up to 40% of patients and is often associated with poor outcomes.

Since January 2023, interns in the South Carolina Science Writing Initiative for Trainees, based in the College of Graduate Studies at the Medical University of South Carolina, have been able to earn digital badges in science communications. A study published in the Journal of Clinical and Translational Science describes how this program helps graduate students and postdoctoral fellows to build communication skills that support community engagement, scientific understanding and career readiness.

Scientists at Oregon State University have developed a new nanomaterial that triggers a pair of chemical reactions inside cancer cells, killing the cells via oxidative stress while leaving healthy tissues alone.

Epidermal growth factor receptor (EGFR) signaling in the tissue around oral cancers both increases nerve sensitivity and makes opioids less effective, according to new research published in Science Signaling.

The findings point to a shared mechanism underlying both oral cancer pain and opioid tolerance—and a possible new treatment strategy for both.